Brief: AtriCure Receives Expanded CE-Mark Indication for AtriClip Devices
Aug 22 (Reuters) - AtriCure Inc ATRC.O :
* ATRICURE RECEIVES EXPANDED CE-MARK INDICATION FOR
ATRICLIP®
DEVICES FOR THE REDUCTION OF STROKE IN PATIENTS WITH ATRIAL
FIBRILLATION
Source text for Eikon: ID:nBwc99n4ka
Further company coverage: ATRC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AtriCure
See all newsAtriCure Q1 revenue beats estimates, co raises 2026 outlook
Brief: AtriCure Q1 Revenue USD 141.2 Million Vs. IBES Estimate USD 139.8 Million
AtriCure beats Q4 profit estimates
Brief: AtriCure Q4 Adjusted EPS USD 0.06 Vs. IBES Estimate USD -0.1
AtriCure's preliminary Q4 revenue rises 13%, slightly beats estimates